These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6172743)
1. Endorphins in schizophrenia. van Ree JM; De Wied D Neuropharmacology; 1981 Dec; 20(12B):1271-7. PubMed ID: 6172743 [No Abstract] [Full Text] [Related]
2. Possible role of opiate receptors and des-tyrosine1-gamma-endorphin in schizophrenia. Pedigo NW; Reisine TD; Schallert T; Overstreet DH; Ling NC; Ragan P; Yamamura HI Adv Biochem Psychopharmacol; 1980; 22():549-62. PubMed ID: 6104903 [No Abstract] [Full Text] [Related]
3. [The endorphin hypothesis of schizophrenia]. Słowik S Psychiatr Pol; 1982; 16(1-2):91-9. PubMed ID: 6292978 [No Abstract] [Full Text] [Related]
4. [The endorphin system and mental diseases in the light of the hedonistic theory (author's transl)]. Giziński W Psychiatr Pol; 1981; 15(2):195-201. PubMed ID: 6273958 [No Abstract] [Full Text] [Related]
5. Clinical studies on the role of endorphins in schizophrenia. Berger PA; Watson SJ; Akil H; Barchas JD Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727 [No Abstract] [Full Text] [Related]
6. The interaction between gamma-type endorphins and HLA class I antigens. Claas FH; van Ree JM; Verhoeven WM; van der Poel JJ; Verduyn W; de Wied D; van Rood JJ Hum Immunol; 1986 Apr; 15(4):347-56. PubMed ID: 2422143 [TBL] [Abstract][Full Text] [Related]
8. The treatment of schizophrenic psychoses with gamma-type endorphins. van Praag HM; Verhoeven WM; van Ree JM; de Wied D Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158 [TBL] [Abstract][Full Text] [Related]
9. [The role of biologically active substances in the control of pain syndrome (review of the literature)]. Puzin MN; Kushlinskiĭ NE; Rushanov MI; Seleznev AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(11):129-35. PubMed ID: 2483014 [No Abstract] [Full Text] [Related]
14. Deficiency in the opioid hypotheses of self-injurious behavior. King BH; McCracken JT; Poland RE Am J Ment Retard; 1991 May; 95(6):692-4; discussion 694-6. PubMed ID: 1647799 [No Abstract] [Full Text] [Related]
15. The structural characterization of beta-endorphin and related peptide hormones and neurotransmitters. Taylor JW; Kaiser ET Pharmacol Rev; 1986 Dec; 38(4):291-319. PubMed ID: 2879295 [No Abstract] [Full Text] [Related]
16. Binding sites for non-opioid gamma-type endorphins in brain structures of the mesocorticolimbic feedback circuit. Wiegant VM; Ronken E; de Boer T; Tonnaer JA Prog Clin Biol Res; 1990; 328():29-32. PubMed ID: 1689494 [No Abstract] [Full Text] [Related]
19. Behavioral effects of opioid receptor antagonists in psychopathologic states. Janowsky DS; Judd LL; Huey LY; Risch SC; Segal DS Psychiatr Clin North Am; 1983 Sep; 6(3):403-14. PubMed ID: 6316300 [No Abstract] [Full Text] [Related]
20. The use of the synthetic peptides gamma-type endorphins in mentally ill patients. van Ree JM; Verhoeven WM; de Wied D; van Praag HM Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176 [No Abstract] [Full Text] [Related] [Next] [New Search]